APA (7th ed.) Citation

Hossam M Elsaadany, Mohammed F Almaghraby, Awatif A Edrees, Yasser M Elsherbiny, & Roobina K Kumar. (2016). Utility of fecal calprotectin as a discriminative biomarker between ulcerative colitis and irritable bowel syndrome and its ability to be used for the assessment of the remission stage of ulcerative colitis. SpringerOpen.

Chicago Style (17th ed.) Citation

Hossam M Elsaadany, Mohammed F Almaghraby, Awatif A Edrees, Yasser M Elsherbiny, and Roobina K Kumar. Utility of Fecal Calprotectin as a Discriminative Biomarker Between Ulcerative Colitis and Irritable Bowel Syndrome and Its Ability to Be Used for the Assessment of the Remission Stage of Ulcerative Colitis. SpringerOpen, 2016.

MLA (9th ed.) Citation

Hossam M Elsaadany, et al. Utility of Fecal Calprotectin as a Discriminative Biomarker Between Ulcerative Colitis and Irritable Bowel Syndrome and Its Ability to Be Used for the Assessment of the Remission Stage of Ulcerative Colitis. SpringerOpen, 2016.